Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Treatment of ductal carcinoma in situ varies widely in United States
April 6th, 2004
A new study has found that treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential overtreatment with aggressive surgical therapy to possible undertreatment by not providing radiation therapy after breast-conserving surgery, according to the study, published in the March 17, 2004, issue of the Journal of the National Cancer Institute (J Natl Cancer Inst, 2004;96:443-8). The incidence of DCIS has increased dramatically in the last few decades, largely because of increased rates of screening mammography. In some cases, DCIS can...
Source: Cancer Weekly (2004-04-06)
|
